Literature DB >> 21199062

Persistence of acute rheumatic fever in a tertiary children's hospital.

Michael T Smith1, David Lester-Smith, Yvonne Zurynski, Sara Noonan, Jonathan R Carapetis, Elizabeth J Elliott.   

Abstract

AIM: To identify and describe all children admitted with acute rheumatic fever (ARF) to a tertiary paediatric hospital in Sydney over a 9-year period and to describe their demographic and clinical characteristics, management and short-term outcomes. Delays in diagnosis, recurrence of ARF and use of secondary prophylaxis were also documented.
METHODS: Retrospective review of medical records for children aged < 15 years admitted to the Children's Hospital at Westmead, Sydney, with ARF (International Classification of Diseases (ICD)-10 classification I0.0-109.9) during 2000-2008. Only cases meeting the National Heart Foundation of Australia diagnostic criteria for ARF were included.
RESULTS: Twenty-six children met the National Heart Foundation of Australia criteria for ARF. The median age was 11.5 years (range 5.8-14.6) and 15 (58%) were male. Ten (38%) identified as Pacific Islander, and 5 (19%) as Aboriginal and Torres Strait Islander (ATSI). Most (n= 20, 77%) lived in suburban Sydney, and 69% were classified in the two most disadvantaged quintiles on the Index of Relative Socioeconomic Disadvantage and Advantage. Four (15%) had Sydenham's chorea, and 81% had carditis (mitral and/or aortic regurgitation). Six (23%) children had previous ARF. Antibiotic prophylaxis to prevent recurrent ARF was prescribed in all cases, but 50% received oral penicillin, rather than by intramuscular injection. Barriers to timely diagnosis were identified in 81%, including delayed presentation and delayed referral.
CONCLUSION: Most children presenting to the hospital with ARF lived in disadvantaged areas of Sydney. Pacific Islander and Aboriginal and Torres Strait Islander children were over-represented. Mitigation of RHD requires early identification of ARF and appropriate delivery of secondary prophylaxis.
© 2010 The Authors. Journal of Paediatrics and Child Health © 2010 Paediatrics and Child Health Division (Royal Australasian College of Physicians).

Entities:  

Mesh:

Year:  2010        PMID: 21199062     DOI: 10.1111/j.1440-1754.2010.01935.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  5 in total

1.  Rheumatic fever and rheumatic heart disease among children presenting to two referral hospitals in Harare, Zimbabwe.

Authors:  P Gapu; M Bwakura-Dangarembizi; G Kandawasvika; D Kao; C Bannerman; J Hakim; J A Matenga
Journal:  S Afr Med J       Date:  2015-06-05

2.  Rheumatic Myocarditis: A Poorly Recognized Etiology of Left Ventricular Dysfunction in Valvular Heart Disease Patients.

Authors:  Vitor Emer Egypto Rosa; Mariana Pezzute Lopes; Guilherme Sobreira Spina; Jose Soares Junior; David Salazar; Cristhian Espinoza Romero; Marcos Pita Lottenberg; Antonio de Santis; Lucas José Neves Tachotti Pires; Luis Fernando Tonello Gonçalves; Joao Ricardo Cordeiro Fernandes; Roney Orismar Sampaio; Flavio Tarasoutchi
Journal:  Front Cardiovasc Med       Date:  2021-06-10

3.  Prognostic value of clinical and Doppler echocardiographic findings in children and adolescents with significant rheumatic valvular disease.

Authors:  Fátima Derlene da Rocha Araújo; Eugênio Marcos Andrade Goulart; Zilda Maria Alves Meira
Journal:  Ann Pediatr Cardiol       Date:  2012-07

Review 4.  The role of social determinants of health in the risk and prevention of group A streptococcal infection, acute rheumatic fever and rheumatic heart disease: A systematic review.

Authors:  Pasqualina M Coffey; Anna P Ralph; Vicki L Krause
Journal:  PLoS Negl Trop Dis       Date:  2018-06-13

5.  Quality of benzathine penicillin G: A multinational cross-sectional study.

Authors:  Robert M Hand; S M D K Ganga Senarathna; Madhu Page-Sharp; Katherine Gray; Dianne Sika-Paotonu; Meru Sheel; Victor T G Chuang; Jorge Martinez; Giuseppe Luna; Laurens Manning; Rosemary Wyber; Jonathan R Carapetis; Kevin T Batty
Journal:  Pharmacol Res Perspect       Date:  2020-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.